Critical process for how breast cancer spreads in bones
Researchers have identified a pair of proteins believed to be critical for spreading, or metastasizing, breast cancer to bone.
Read moreLung Cancer
Diabetes advances poised to help manage blood sugar after meals
Mealtimes can become a difficult experience for individuals with diabetes. After a meal, blood sugar levels may soar as the food digests or unexpectedly plummet if an insulin dose was more than the meal required.
Read moreNew evolution-busting drug overcomes resistance in aggressive breast cancers
A new type of drug that blocks one of cancer's key evolutionary escape routes from chemotherapy could be used to treat aggressive breast cancers, a new study has shown.
Read moreMicrobiome provides new clues to determining development of colon cancer
Findings showcasing a connection between bacteria in the microbiome and colon cancer, which may be used to screen younger populations at risk.
Read moreAggressive breast cancers store large amounts of energy, which enables it to spread
Researchers found that aggressive breast cancers store glycogen in very large amounts, offering an explanation of how cells can change their function to evade treatment, grow and spread. Targeting an enzyme involved in this process could potentially treat or prevent metastases.
Read moreScientist designs 'express courier service' for immune cells
A researcher who is currently doing his post-doctoral training at Stanford University, has successfully invented a novel transfection method to deliver DNA into immune cells with minimal stress on these cells. This new technique is expected to boost DNA-based cancer immunotherapy by significantly improving the process of generating high-quality genetically modified immune cells.
Read moreThe 'Goldilocks' principle for curing brain cancer
Researchers found that a stable body temperature holds the key to awakening the body's immune response to fight off brain cancer.
Read moreIbrutinib linked to high blood pressure and other heart problems, study suggests
Over half of people prescribed the targeted blood cancer-fighting drug ibrutinib developed new or worsened high blood pressure within six months of starting the medication. The analysis is also the first to tie ibrutinib-related hypertension to a heightened risk of heart problems, particularly atrial fibrillation. Moreover, the association of ibrutinib with cardiovascular complications remained regardless of the prescribed dose.
Read moreTargeting regulator of mitochondrial cell death delivers anticancer activity
A novel anticancer molecule created by researchers showed therapeutic activity in preclinical models of various cancer types.
Read moreProtein associated with many diseases fully visualized for first time
For the first time, researchers have learned at the molecular level how the P2X7 protein receptor – which is associated with inflammation, coronary artery disease, cancer, multiple sclerosis and more – works. The findings could one day inspire new drugs to treat numerous medical conditions.
Read more